Filing Details
- Accession Number:
- 0001209191-13-031639
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-11 17:13:56
- Reporting Period:
- 2013-06-07
- Filing Date:
- 2013-06-11
- Accepted Time:
- 2013-06-11 17:13:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1333248 | Cadence Pharmaceuticals Inc | CADX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1466916 | A. Scott Byrd | C/O Cadence Pharmaceuticals, Inc. 12481 High Bluff Drive, Ste 200 San Diego CA 92130 | Svp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-06-07 | 30,657 | $3.51 | 32,657 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-06-07 | 36,458 | $3.51 | 69,115 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-07 | 67,115 | $7.53 | 2,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | stock option (right to buy) | Disposition | 2013-06-07 | 30,657 | $0.00 | 30,657 | $3.51 |
| Common Stock | stock option (right to buy) | Disposition | 2013-06-07 | 36,458 | $0.00 | 36,458 | $3.51 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2012-09-14 | 2022-03-14 | No | 4 | M | Direct |
| 88,542 | 2022-03-14 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2013.
- This transaction was executed in multiple trades at prices ranging from a low of $7.39 to a high of $7.79. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Not applicable to this transaction.
- 31,250 of the options vested and became exercisable on March 14, 2013; and 2,604 of the options vested and became exercisable on each of April 1, 2013 and May 1, 2013.
Billionaire Hedge Funds
